Abstract

Estradiol 0.1% Vaginal Solution

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2008 - Veterinary Compounding

Page(s): 450

Download in electronic PDF format for $75
  • Estradiol 0.1% Vaginal Solution Page 1

Abstract

A formulation for preparing Estradiol 0.1% Vaginal Solution. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • beta estradiol
  • estrogen
  • hormone replacement therapy
  • intravaginal administration
  • vaginal preparation
  • vaginosis
  • vaginal infection

Related Categories

  • FORMULATIONS
  • HRT
  • DOSAGE FORMS/DRUG CARRIERS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2008
Pg. 450
Estradiol 0.1% Vaginal Solution
Author(s): Allen Loyd V Jr
Jan/Feb 2024
Pg. 58
Estradiol 0.1% Vaginal Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 456-465
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome
Author(s): Riepl Mike
Nov/Dec 2009
Pg. 556
Gentian Violet Vaginal Suppositories
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 447-454
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Author(s): Deleruyelle Laura J
Jul/Aug 2009
Pg. 338
Mupirocin 1% (20-mg) Vaginal Suppository
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 52-54
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Author(s): Ford Gina, Garcia Lea
Jul/Aug 2016
Pg. 322
Nystatin 100,000-units Vaginal Inserts
Author(s): Allen Loyd V Jr
Mar/Apr 2023
Pg. 108-112
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Jan/Feb 2019
Pg. 77-81
Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Author(s): Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
May/Jun 2018
Pg. 196-202
Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications
Author(s): Agbi Kelechi E, Hover Sara, Carvalho Maria
Jul/Aug 2009
Pg. 334
Clindamycin 100-mg Vaginal Suppositories
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 250-256
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Author(s): Gillson George R, Zava David T
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
May/Jun 2018
Pg. 190-195
Establishing a Rationale for Compounding Hormone Replacement Therapy
Author(s): Biundo Bruce
Jan/Feb 2024
Pg. 22-27
Establishing a Rationale for Compounding Hormone Replacement Therapy
Author(s): Biundo Bruce
Mar/Apr 2012
Pg. 110-114
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Author(s): Griffee Chris, Delano Amy
Nov/Dec 2018
Pg. 504-511
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase)
Author(s): Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
Sep/Oct 2001
Pg. 375
Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream
Author(s): Allen Loyd V Jr
Jan/Feb 1998
Pg. 48
Estradiol 1-mg Vaginal Suppositories
Author(s): Allen Loyd V Jr